| term overlap_mean setsize_mean score_mean pval_mean overlap_std setsize_std score_std pval_std |
| 2 ltr circle formation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| A tetrasaccharide linker sequence is required for gag synthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir transmembrane transport 1.0 2.0 10.0 0.0476744094315084 0.0 0.0 0.0 0.0 |
| Abacavir transport and metabolism 1.0 6.0 8.118367346938776 0.1363381791325428 0.0 0.0 0.0 0.0 |
| Abc family proteins mediated transport 4.0 75.0 2.2998486788499592 0.1071524979756758 0.0 0.0 0.0 0.0 |
| Abc transporter disorders 2.0 61.0 1.374131703250903 0.4350801141331635 0.0 0.0 0.0 0.0 |
| Abc transporters in lipid homeostasis 1.0 7.0 6.764625850340136 0.1571881112173651 0.0 0.0 0.0 0.0 |
| Aberrant regulation of mitotic exit in cancer due to rb1 defects 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aberrant regulation of mitotic g1 s transition in cancer due to rb1 defects 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abortive elongation of hiv 1 transcript in the absence of tat 1.0 23.0 1.8419294990723565 0.4301270919610729 0.0 0.0 0.0 0.0 |
| Acetylcholine binding and downstream events 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acetylcholine neurotransmitter release cycle 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acetylcholine regulates insulin secretion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acrosome reaction and sperm oocyte membrane binding 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated notch1 transmits signal to the nucleus 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through cdk5 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through frs2 and frs3 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through fyn 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through pi3k 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through ras 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk3 signals through pi3k 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk3 signals through ras 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated pkn1 stimulates transcription of ar androgen receptor regulated genes klk2 and klk3 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated tak1 mediates p38 mapk activation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ampk downstream of nmdars 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of anterior hox genes in hindbrain development during early embryogenesis 0.0 60.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of atr in response to replication stress 1.0 38.0 1.0935466078323222 0.6053596540060717 0.0 0.0 0.0 0.0 |
| Activation of bad and translocation to mitochondria 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of bh3 only proteins 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of c3 and c5 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of caspases through apoptosome mediated cleavage 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of gene expression by srebf srebp 4.0 42.0 4.311439756415833 0.0180565405233996 0.0 0.0 0.0 0.0 |
| Activation of irf3 irf7 mediated by tbk1 ikk epsilon 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of kainate receptors upon glutamate binding 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of matrix metalloproteinases 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of nima kinases nek9 nek6 nek7 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of nmda receptors and postsynaptic events 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of noxa and translocation to mitochondria 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ppargc1a pgc 1alpha by phosphorylation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of puma and translocation to mitochondria 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of rac1 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of rac1 downstream of nmdars 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ras in b cells 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of smo 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the ap 1 family of transcription factors 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the mrna upon binding of the cap binding complex and eifs and subsequent binding to 43s 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the phototransduction cascade 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the pre replicative complex 1.0 33.0 1.2650510204081633 0.5539124029112868 0.0 0.0 0.0 0.0 |
| Activation of the tfap2 ap 2 family of transcription factors 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of trka receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodeling of cl 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodeling of dag and tag 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pc 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pe 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pg 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pi 1.0 4.0 10.0 0.0930847686914372 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of ps 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adaptive immune system 6.0 504.0 0.4744979919678715 0.984540753813802 0.0 0.0 0.0 0.0 |
| Adenylate cyclase activating pathway 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adenylate cyclase inhibitory pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adherens junctions interactions 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adora2b mediated anti inflammatory cytokines production 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adp signalling through p2y purinoceptor 1 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adp signalling through p2y purinoceptor 12 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adrenaline noradrenaline inhibits insulin secretion 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Advanced glycosylation endproduct receptor signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aflatoxin activation and detoxification 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aggrephagy 1.0 34.0 1.2265924551638838 0.5647101544543685 0.0 0.0 0.0 0.0 |
| Akt phosphorylates targets in the cytosol 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Akt phosphorylates targets in the nucleus 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alk mutants bind tkis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha defensins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha linolenic omega3 and linoleic omega6 acid metabolism 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha oxidation of phytanate 1.0 6.0 8.118367346938776 0.1363381791325428 0.0 0.0 0.0 0.0 |
| Alpha protein kinase 1 signaling pathway 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alternative complement activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amino acid transport across the plasma membrane 1.0 17.0 2.534183673469388 0.3400030327298383 0.0 0.0 0.0 0.0 |
| Amino acids regulate mtorc1 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ampk inhibits chrebp transcriptional activation activity 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amyloid fiber formation 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anchoring fibril formation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anchoring of the basal body to the plasma membrane 4.0 95.0 1.790754699845609 0.1965656491382458 0.0 0.0 0.0 0.0 |
| Androgen biosynthesis 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anti inflammatory response favouring leishmania parasite infection 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen activates b cell receptor bcr leading to generation of second messengers 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen presentation folding assembly and peptide loading of class i mhc 1.0 24.0 1.7616681455190772 0.4439075633632242 0.0 0.0 0.0 0.0 |
| Antigen processing cross presentation 2.0 77.0 1.0792349726775956 0.5580999148109159 0.0 0.0 0.0 0.0 |
| Antigen processing ubiquitination proteasome degradation 3.0 250.0 0.4849802569100814 0.9436776162664352 0.0 0.0 0.0 0.0 |
| Antimicrobial peptides 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antiviral mechanism by ifn stimulated genes 1.0 73.0 0.5599773242630386 0.8329191570462157 0.0 0.0 0.0 0.0 |
| Apc c cdc20 mediated degradation of cyclin b 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1 1.0 68.0 0.6020712762717028 0.8110566761636493 0.0 0.0 0.0 0.0 |
| Apc c mediated degradation of cell cycle proteins 1.0 81.0 0.5035714285714286 0.8627781534140635 0.0 0.0 0.0 0.0 |
| Apc cdc20 mediated degradation of nek2a 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apex1 independent resolution of ap sites via the single nucleotide replacement pathway 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apobec3g mediated resistance to hiv 1 infection 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptosis 3.0 159.0 0.7750870528648306 0.7427317979686745 0.0 0.0 0.0 0.0 |
| Apoptosis induced dna fragmentation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic cleavage of cell adhesion proteins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic cleavage of cellular proteins 1.0 35.0 1.190396158463385 0.5752475783862557 0.0 0.0 0.0 0.0 |
| Apoptotic execution phase 1.0 47.0 0.878793256433008 0.6835238209809511 0.0 0.0 0.0 0.0 |
| Apoptotic factor mediated response 1.0 20.0 2.133404940923738 0.3867116248199588 0.0 0.0 0.0 0.0 |
| Aquaporin mediated transport 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arachidonate production from dag 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arachidonic acid metabolism 2.0 18.0 5.089139344262295 0.0688460117016781 0.0 0.0 0.0 0.0 |
| Arms mediated activation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aryl hydrocarbon receptor signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Asparagine n linked glycosylation 12.0 245.0 2.1386596236381643 0.0156781371910223 0.0 0.0 0.0 0.0 |
| Aspartate and asparagine metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly and cell surface presentation of nmda receptors 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of active lpl and lipc lipase complexes 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of collagen fibrils and other multimeric structures 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of the hiv virion 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of the orc complex at the origin of replication 1.0 20.0 2.133404940923738 0.3867116248199588 0.0 0.0 0.0 0.0 |
| Association of tric cct with target proteins during biosynthesis 1.0 36.0 1.156268221574344 0.5855309260576435 0.0 0.0 0.0 0.0 |
| Asymmetric localization of pcp proteins 1.0 54.0 0.762187139006546 0.7334839427632852 0.0 0.0 0.0 0.0 |
| Atf4 activates genes in response to endoplasmic reticulum stress 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Atf6 atf6 alpha activates chaperone genes 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Atf6 atf6 alpha activates chaperones 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attachment and entry 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attachment of gpi anchor to upar 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attenuation phase 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Auf1 hnrnp d0 binds and destabilizes mrna 1.0 48.0 0.8600086843247937 0.6911948368646196 0.0 0.0 0.0 0.0 |
| Aurka activation by tpx2 4.0 73.0 2.366990058689664 0.0994768290011166 0.0 0.0 0.0 0.0 |
| Autophagy 4.0 130.0 1.2887314705496524 0.3838491086472183 0.0 0.0 0.0 0.0 |
| B wich complex positively regulates rrna expression 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Base excision repair 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Base excision repair ap site formation 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Basigin interactions 1.0 16.0 2.703401360544217 0.3236592382947187 0.0 0.0 0.0 0.0 |
| Bbsome mediated cargo targeting to cilium 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta catenin independent wnt signaling 1.0 117.0 0.3460239268121041 0.9435311640733663 0.0 0.0 0.0 0.0 |
| Beta catenin phosphorylation cascade 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of butanoyl coa to acetyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of decanoyl coa to octanoyl coa coa 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of hexanoyl coa to butanoyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of lauroyl coa to decanoyl coa coa 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of octanoyl coa to hexanoyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of pristanoyl coa 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of very long chain fatty acids 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bh3 only proteins associate with and inactivate anti apoptotic bcl 2 members 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bicarbonate transporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bile acid and bile salt metabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Binding and uptake of ligands by scavenger receptors 1.0 17.0 2.534183673469388 0.3400030327298383 0.0 0.0 0.0 0.0 |
| Binding of tcf lef ctnnb1 to target gene promoters 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biological oxidations 7.0 94.0 3.3203962872120427 0.0075397092471439 0.0 0.0 0.0 0.0 |
| Biosynthesis of epa derived spms 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of maresins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of specialized proresolving mediators spms 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of the n glycan precursor dolichol lipid linked oligosaccharide llo and transfer to a nascent protein 4.0 59.0 2.9737039819684448 0.053649406266927 0.0 0.0 0.0 0.0 |
| Biotin transport and metabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Blood group systems biosynthesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bmal1 clock npas2 activates circadian gene expression 1.0 20.0 2.133404940923738 0.3867116248199588 0.0 0.0 0.0 0.0 |
| Branched chain amino acid catabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Budding and maturation of hiv virion 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Butyrate response factor 1 brf1 binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Butyrophilin btn family interactions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| C type lectin receptors clrs 1.0 100.0 0.4061430632859204 0.9140832188695428 0.0 0.0 0.0 0.0 |
| Ca dependent events 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ca2 pathway 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Calcineurin activates nfat 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Calnexin calreticulin cycle 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Camk iv mediated phosphorylation of creb 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Carboxyterminal post translational modifications of tubulin 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cardiac conduction 1.0 43.0 0.9628765792031098 0.6508948194595567 0.0 0.0 0.0 0.0 |
| Cargo concentration in the er 2.0 23.0 3.875487900078064 0.1053546389470493 0.0 0.0 0.0 0.0 |
| Cargo recognition for clathrin mediated endocytosis 1.0 78.0 0.5233501192684866 0.8522610344387342 0.0 0.0 0.0 0.0 |
| Cargo trafficking to the periciliary membrane 3.0 43.0 3.058641975308642 0.0846608217542885 0.0 0.0 0.0 0.0 |
| Carnitine metabolism 2.0 12.0 8.147540983606557 0.032628233248221 0.0 0.0 0.0 0.0 |
| Caspase activation via death receptors in the presence of ligand 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via dependence receptors in the absence of ligand 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via extrinsic apoptotic signalling pathway 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase mediated cleavage of cytoskeletal proteins 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Cation coupled chloride cotransporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd163 mediating an anti inflammatory response 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd209 dc sign signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd22 mediated bcr regulation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 co stimulation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 dependent pi3k akt signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 dependent vav1 pathway 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cdc42 gtpase cycle 3.0 134.0 0.9253604749787956 0.631719227962056 0.0 0.0 0.0 0.0 |
| Cdc6 association with the orc origin complex 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Cdt1 association with the cdc6 orc origin complex 2.0 54.0 1.5602143757881464 0.3757594500595086 0.0 0.0 0.0 0.0 |
| Cell cell communication 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell cell junction organization 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell cycle 13.0 613.0 0.8694563662374821 0.7250478075359919 0.0 0.0 0.0 0.0 |
| Cell cycle checkpoints 2.0 257.0 0.3116361298617808 0.9869640134323292 0.0 0.0 0.0 0.0 |
| Cell cycle mitotic 13.0 498.0 1.0888456262997213 0.4257515054631132 0.0 0.0 0.0 0.0 |
| Cell death signalling via nrage nrif and nade 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell extracellular matrix interactions 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell junction organization 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell surface interactions at the vascular wall 1.0 70.0 0.5845016267376516 0.8201241756611954 0.0 0.0 0.0 0.0 |
| Cellular hexose transport 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular response to chemical stress 6.0 133.0 1.9336614173228344 0.1025504387159284 0.0 0.0 0.0 0.0 |
| Cellular response to heat stress 1.0 93.0 0.4373558118899733 0.8978967157475708 0.0 0.0 0.0 0.0 |
| Cellular response to hypoxia 1.0 59.0 0.6961294862772696 0.7642817903060852 0.0 0.0 0.0 0.0 |
| Cellular response to starvation 0.0 139.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular responses to stimuli 14.0 614.0 0.9403735632183908 0.626500700767663 0.0 0.0 0.0 0.0 |
| Cellular senescence 0.0 131.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cgmp effects 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chaperone mediated autophagy 1.0 16.0 2.703401360544217 0.3236592382947187 0.0 0.0 0.0 0.0 |
| Chemokine receptors bind chemokines 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chk1 chk2 cds1 mediated inactivation of cyclin b cdk1 complex 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chl1 interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cholesterol biosynthesis 7.0 24.0 10.0 1.0652118507020126e-06 0.0 0.0 0.0 0.0 |
| Choline catabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chondroitin sulfate biosynthesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chondroitin sulfate dermatan sulfate metabolism 2.0 32.0 2.710382513661202 0.1800390494619342 0.0 0.0 0.0 0.0 |
| Chrebp activates metabolic gene expression 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chromatin modifying enzymes 0.0 210.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chromosome maintenance 0.0 100.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron assembly 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron clearance 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron remodeling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cilium assembly 7.0 183.0 1.62652149106124 0.1540016805198659 0.0 0.0 0.0 0.0 |
| Circadian clock 1.0 55.0 0.7479969765684051 0.7399484418736413 0.0 0.0 0.0 0.0 |
| Citric acid cycle tca cycle 1.0 21.0 2.026530612244898 0.4015375820029667 0.0 0.0 0.0 0.0 |
| Class a 1 rhodopsin like receptors 3.0 21.0 6.812071330589849 0.0133829456596615 0.0 0.0 0.0 0.0 |
| Class b 2 secretin family receptors 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Class i mhc mediated antigen processing presentation 4.0 295.0 0.5486353696288092 0.9294461076335552 0.0 0.0 0.0 0.0 |
| Class i peroxisomal membrane protein import 3.0 19.0 7.665123456790123 0.0101015401572799 0.0 0.0 0.0 0.0 |
| Clathrin mediated endocytosis 1.0 119.0 0.3400899342787962 0.9462541488522834 0.0 0.0 0.0 0.0 |
| Clec7a dectin 1 induces nfat activation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Clec7a dectin 1 signaling 1.0 85.0 0.4793974732750243 0.8756499730029537 0.0 0.0 0.0 0.0 |
| Clec7a inflammasome pathway 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cobalamin cbl vitamin b12 transport and metabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Coenzyme a biosynthesis 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cohesin loading onto chromatin 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen biosynthesis and modifying enzymes 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen chain trimerization 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen degradation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen formation 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Common pathway of fibrin clot formation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Competing endogenous rnas cernas regulate pten translation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Complement cascade 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Complex i biogenesis 5.0 56.0 4.026930274184362 0.0110236812642753 0.0 0.0 0.0 0.0 |
| Condensation of prometaphase chromosomes 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Condensation of prophase chromosomes 1.0 23.0 1.8419294990723565 0.4301270919610729 0.0 0.0 0.0 0.0 |
| Constitutive signaling by aberrant pi3k in cancer 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by akt1 e17k in cancer 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by egfrviii 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by ligand responsive egfr cancer variants 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by overexpressed erbb2 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Conversion from apc c cdc20 to apc c cdh1 in late anaphase 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cooperation of pdcl phlp1 and tric cct in g protein beta folding 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cooperation of prefoldin and tric cct in actin and tubulin folding 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Copi dependent golgi to er retrograde traffic 6.0 83.0 3.2055194805194804 0.0149319876934548 0.0 0.0 0.0 0.0 |
| Copi independent golgi to er retrograde traffic 2.0 45.0 1.8884864658787648 0.2961580697833918 0.0 0.0 0.0 0.0 |
| Copi mediated anterograde transport 6.0 89.0 2.971987951807229 0.0204257314217003 0.0 0.0 0.0 0.0 |
| Copii mediated vesicle transport 1.0 55.0 0.7479969765684051 0.7399484418736413 0.0 0.0 0.0 0.0 |
| Costimulation by the cd28 family 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creatine metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb phosphorylation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through nmda receptor mediated activation of ras signaling 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through the activation of adenylate cyclase 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through the activation of camkii camkk camkiv cascasde 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb3 factors activate genes 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cristae formation 5.0 27.0 9.36250471520181 0.0004102788019959 0.0 0.0 0.0 0.0 |
| Crmps in sema3a signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cross presentation of particulate exogenous antigens phagosomes 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cross presentation of soluble exogenous antigens endosomes 1.0 41.0 1.0112244897959184 0.6333450487016228 0.0 0.0 0.0 0.0 |
| Crosslinking of collagen fibrils 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cs ds degradation 1.0 7.0 6.764625850340136 0.1571881112173651 0.0 0.0 0.0 0.0 |
| Ctla4 inhibitory signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyclin a b1 b2 associated events during g2 m transition 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyclin a cdk2 associated events at s phase entry 1.0 79.0 0.5165881737310308 0.8558530274917338 0.0 0.0 0.0 0.0 |
| Cyclin d associated events in g1 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyp2e1 reactions 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytochrome c mediated apoptotic response 1.0 13.0 3.380272108843537 0.2721697661507766 0.0 0.0 0.0 0.0 |
| Cytochrome p450 arranged by substrate type 2.0 15.0 6.265447667087011 0.0495157384890535 0.0 0.0 0.0 0.0 |
| Cytokine signaling in immune system 5.0 392.0 0.5126679318515659 0.9630168214363805 0.0 0.0 0.0 0.0 |
| Cytoprotection by hmox1 6.0 110.0 2.366826923076923 0.0499303136470245 0.0 0.0 0.0 0.0 |
| Cytosolic iron sulfur cluster assembly 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic sensors of pathogen associated dna 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic sulfonation of small molecules 1.0 14.0 3.119937205651492 0.2897526236095206 0.0 0.0 0.0 0.0 |
| Cytosolic trna aminoacylation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dag and ip3 signaling 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dap12 interactions 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dap12 signaling 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Darpp 32 events 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dcc mediated attractive signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ddx58 ifih1 mediated induction of interferon alpha beta 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deactivation of the beta catenin transactivating complex 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deadenylation dependent mrna decay 1.0 57.0 0.7211370262390671 0.7524126639072135 0.0 0.0 0.0 0.0 |
| Deadenylation of mrna 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Death receptor signalling 1.0 120.0 0.3371977362373521 0.9475661940478052 0.0 0.0 0.0 0.0 |
| Dectin 1 mediated noncanonical nf kb signaling 1.0 53.0 0.7769230769230769 0.726859415108312 0.0 0.0 0.0 0.0 |
| Dectin 2 family 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective b4galt1 causes b4galt1 cdg cdg 2d 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective b4galt7 causes eds progeroid type 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective c1galt1c1 causes tnps 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective cftr causes cystic fibrosis 2.0 54.0 1.5602143757881464 0.3757594500595086 0.0 0.0 0.0 0.0 |
| Defective chst14 causes eds musculocontractural type 1.0 4.0 10.0 0.0930847686914372 0.0 0.0 0.0 0.0 |
| Defective chst3 causes sedcjd 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chst6 causes mcdc1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chsy1 causes tpbs 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective ext2 causes exostoses 2 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective f9 activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective factor ix causes hemophilia b 1.0 3.0 10.0 0.0706557803630322 0.0 0.0 0.0 0.0 |
| Defective factor viii causes hemophilia a 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective galnt3 causes hftc 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective intrinsic pathway for apoptosis 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective lfng causes scdo3 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective ripk1 mediated regulated necrosis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in biotin btn metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in cobalamin b12 metabolism 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in vitamin and cofactor metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects of contact activation system cas and kallikrein kinin system kks 1.0 5.0 10.0 0.1149745986461117 0.0 0.0 0.0 0.0 |
| Defensins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of axin 1.0 48.0 0.8600086843247937 0.6911948368646196 0.0 0.0 0.0 0.0 |
| Degradation of beta catenin by the destruction complex 1.0 77.0 0.5302900107411386 0.8485799055650284 0.0 0.0 0.0 0.0 |
| Degradation of cysteine and homocysteine 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Degradation of dvl 1.0 50.0 0.8247396917950853 0.705985725150242 0.0 0.0 0.0 0.0 |
| Degradation of gli1 by the proteasome 1.0 53.0 0.7769230769230769 0.726859415108312 0.0 0.0 0.0 0.0 |
| Degradation of the extracellular matrix 1.0 56.0 0.7343228200371058 0.7462567628712866 0.0 0.0 0.0 0.0 |
| Depolymerisation of the nuclear lamina 2.0 16.0 5.817330210772834 0.0557098434243155 0.0 0.0 0.0 0.0 |
| Deposition of new cenpa containing nucleosomes at the centromere 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dermatan sulfate biosynthesis 1.0 6.0 8.118367346938776 0.1363381791325428 0.0 0.0 0.0 0.0 |
| Detoxification of reactive oxygen species 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deubiquitination 4.0 221.0 0.7413642076398674 0.7851071240352783 0.0 0.0 0.0 0.0 |
| Developmental biology 3.0 665.0 0.1732124874118832 0.9999912686745526 0.0 0.0 0.0 0.0 |
| Dex h box helicases activate type i ifn and inflammatory cytokines production 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Digestion 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Digestion and absorption 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Disassembly of the destruction complex and recruitment of axin to the membrane 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with glycosaminoglycan metabolism 2.0 26.0 3.3900273224043715 0.1292409073430241 0.0 0.0 0.0 0.0 |
| Diseases associated with glycosylation precursor biosynthesis 2.0 16.0 5.817330210772834 0.0557098434243155 0.0 0.0 0.0 0.0 |
| Diseases associated with n glycosylation of proteins 1.0 18.0 2.384873949579832 0.3559534457378639 0.0 0.0 0.0 0.0 |
| Diseases associated with o glycosylation of proteins 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with surfactant metabolism 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of base excision repair 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of carbohydrate metabolism 2.0 23.0 3.875487900078064 0.1053546389470493 0.0 0.0 0.0 0.0 |
| Diseases of dna repair 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of glycosylation 5.0 76.0 2.8867395242826253 0.0363101363561639 0.0 0.0 0.0 0.0 |
| Diseases of immune system 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of metabolism 6.0 131.0 1.965 0.0971253180165182 0.0 0.0 0.0 0.0 |
| Diseases of mismatch repair mmr 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of mitotic cell cycle 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of programmed cell death 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of signal transduction by growth factor receptors and second messengers 3.0 333.0 0.3598952487841377 0.9883396969977136 0.0 0.0 0.0 0.0 |
| Disinhibition of snare formation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Disorders of transmembrane transporters 4.0 115.0 1.465118010572556 0.3014727885764127 0.0 0.0 0.0 0.0 |
| Displacement of dna glycosylase by apex1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dissolution of fibrin clot 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage bypass 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage recognition in gg ner 1.0 37.0 1.1240362811791382 0.5955662992954859 0.0 0.0 0.0 0.0 |
| Dna damage reversal 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage telomere stress induced senescence 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna double strand break repair 0.0 137.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna double strand break response 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna methylation 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna repair 1.0 291.0 0.1359605911330049 0.999261877764422 0.0 0.0 0.0 0.0 |
| Dna replication 2.0 137.0 0.5959319975713419 0.8473212688211205 0.0 0.0 0.0 0.0 |
| Dna replication initiation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna replication pre initiation 2.0 92.0 0.8979963570127505 0.65511488808051 0.0 0.0 0.0 0.0 |
| Dna strand elongation 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dopamine clearance from the synaptic cleft 1.0 2.0 10.0 0.0476744094315084 0.0 0.0 0.0 0.0 |
| Dopamine neurotransmitter release cycle 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb2 erbb3 signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb2 signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb4 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of smad2 3 smad4 transcriptional activity 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of tgf beta receptor signaling 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signal transduction 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling events of b cell receptor bcr 1.0 71.0 0.5760932944606414 0.8244940603927083 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr1 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr2 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr3 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr4 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dscam interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dual incision in gg ner 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dual incision in tc ner 0.0 67.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| E2f enabled inhibition of pre replication complex formation 1.0 10.0 4.508390022675737 0.2167775624926856 0.0 0.0 0.0 0.0 |
| E2f mediated regulation of dna replication 1.0 23.0 1.8419294990723565 0.4301270919610729 0.0 0.0 0.0 0.0 |
| E3 ubiquitin ligases ubiquitinate target proteins 1.0 40.0 1.037257980115123 0.6242434222626774 0.0 0.0 0.0 0.0 |
| Early phase of hiv life cycle 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ecm proteoglycans 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Effects of pip2 hydrolysis 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr downregulation 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr interacts with phospholipase c gamma 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr transactivation by gastrin 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egr2 and sox10 mediated initiation of schwann cell myelination 2.0 20.0 4.522768670309654 0.0828772873031817 0.0 0.0 0.0 0.0 |
| Eicosanoids 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Elastic fibre formation 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Electric transmission across gap junctions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Elevation of cytosolic ca2 levels 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endogenous sterols 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Endosomal sorting complex required for transport escrt 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endosomal vacuolar pathway 1.0 10.0 4.508390022675737 0.2167775624926856 0.0 0.0 0.0 0.0 |
| Energy dependent regulation of mtor by lkb1 ampk 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Enos activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eph ephrin mediated repulsion of cells 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eph ephrin signaling 0.0 80.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Epha mediated growth cone collapse 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ephb mediated forward signaling 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ephrin signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Epigenetic regulation of gene expression 0.0 102.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Er quality control compartment erqc 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Er to golgi anterograde transport 7.0 129.0 2.3594210851224364 0.0365231070640727 0.0 0.0 0.0 0.0 |
| Erbb2 activates ptk6 signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erbb2 regulates cell motility 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ercc6 csb and ehmt2 g9a positively regulate rrna expression 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erk mapk targets 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erks are inactivated 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythrocytes take up carbon dioxide and release oxygen 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythrocytes take up oxygen and release carbon dioxide 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates phosphoinositide 3 kinase pi3k 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates phospholipase c gamma plcg 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates ras 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates stat5 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Esr mediated signaling 1.0 136.0 0.2967498110355253 0.9647038322361232 0.0 0.0 0.0 0.0 |
| Establishment of sister chromatid cohesion 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen biosynthesis 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen dependent gene expression 1.0 90.0 0.4522357257509745 0.8900614345422548 0.0 0.0 0.0 0.0 |
| Estrogen dependent nuclear events downstream of esr membrane signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen stimulated signaling through prkcz 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ethanol oxidation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eukaryotic translation elongation 0.0 89.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eukaryotic translation initiation 1.0 116.0 0.3490683229813665 0.9421185818427228 0.0 0.0 0.0 0.0 |
| Export of viral ribonucleoproteins from nucleus 1.0 32.0 1.3059907834101383 0.5428479192551358 0.0 0.0 0.0 0.0 |
| Extension of telomeres 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Extra nuclear estrogen signaling 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Extracellular matrix organization 1.0 131.0 0.308320251177394 0.9600542146079176 0.0 0.0 0.0 0.0 |
| Extrinsic pathway of fibrin clot formation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Factors involved in megakaryocyte development and platelet production 0.0 117.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fanconi anemia pathway 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fasl cd95l signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acid metabolism 7.0 117.0 2.6200076074553063 0.0230184986659368 0.0 0.0 0.0 0.0 |
| Fatty acids bound to gpr40 ffar1 regulate insulin secretion 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acyl coa biosynthesis 2.0 29.0 3.012446873102611 0.154226710893935 0.0 0.0 0.0 0.0 |
| Fbxw7 mutants and notch1 in cancer 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fc epsilon receptor fceri signaling 1.0 108.0 0.3754720579820713 0.9294750136879288 0.0 0.0 0.0 0.0 |
| Fceri mediated ca 2 mobilization 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fceri mediated mapk activation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fceri mediated nf kb activation 1.0 68.0 0.6020712762717028 0.8110566761636493 0.0 0.0 0.0 0.0 |
| Fcgamma receptor fcgr dependent phagocytosis 2.0 72.0 1.1569086651053864 0.5217398143434403 0.0 0.0 0.0 0.0 |
| Fcgr activation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fcgr3a mediated il10 synthesis 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fertilization 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1 ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1 mutant receptor activation 1.0 22.0 1.9298347910592808 0.4160065505344545 0.0 0.0 0.0 0.0 |
| Fgfr1b ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1c ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 alternative splicing 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 mutant receptor activation 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2b ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2c ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr3 ligand binding and activation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr3b ligand binding and activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfrl1 modulation of fgfr1 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fibronectin matrix formation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling by cbl mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling in disease 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling through src family kinases 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Folding of actin by cct tric 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of apoptosome 1.0 11.0 4.057142857142857 0.2356930071839008 0.0 0.0 0.0 0.0 |
| Formation of atp by chemiosmotic coupling 3.0 14.0 10.0 0.0041470760753771 0.0 0.0 0.0 0.0 |
| Formation of fibrin clot clotting cascade 1.0 9.0 5.072448979591837 0.1973959389561772 0.0 0.0 0.0 0.0 |
| Formation of incision complex in gg ner 1.0 42.0 0.986460925833748 0.6422270888991375 0.0 0.0 0.0 0.0 |
| Formation of rna pol ii elongation complex 1.0 58.0 0.7084138918725384 0.7584198129875613 0.0 0.0 0.0 0.0 |
| Formation of senescence associated heterochromatin foci sahf 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of tc ner pre incision complex 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of the beta catenin tcf transactivating complex 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of the cornified envelope 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of the early elongation complex 1.0 33.0 1.2650510204081633 0.5539124029112868 0.0 0.0 0.0 0.0 |
| Formation of tubulin folding intermediates by cct tric 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of xylulose 5 phosphate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formyl peptide receptors bind formyl peptides and many other ligands 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of cell cycle genes 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of cell death genes 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of oxidative stress metabolic and neuronal genes 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Free fatty acids regulate insulin secretion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr1 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr2 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr3 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr4 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fructose catabolism 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fructose metabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha 12 13 signalling events 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha i signalling events 2.0 88.0 0.9401448722836446 0.6310183571164482 0.0 0.0 0.0 0.0 |
| G alpha q signalling events 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha s signalling events 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha z signalling events 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G beta gamma signalling through cdc42 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G beta gamma signalling through pi3kgamma 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein activation 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein beta gamma signalling 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein mediated events 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G0 and early g1 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G1 s dna damage checkpoints 1.0 61.0 0.6727891156462585 0.7755841231055027 0.0 0.0 0.0 0.0 |
| G1 s specific transcription 2.0 29.0 3.012446873102611 0.154226710893935 0.0 0.0 0.0 0.0 |
| G2 m checkpoints 2.0 134.0 0.6096621957277695 0.838378064229569 0.0 0.0 0.0 0.0 |
| G2 m dna damage checkpoint 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 m dna replication checkpoint 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 phase 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gab1 signalosome 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba b receptor activation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba receptor activation 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba synthesis release reuptake and degradation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Galactose catabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gamma carboxylation hypusine formation and arylsulfatase activation 2.0 29.0 3.012446873102611 0.154226710893935 0.0 0.0 0.0 0.0 |
| Gamma carboxylation transport and amino terminal cleavage of proteins 1.0 5.0 10.0 0.1149745986461117 0.0 0.0 0.0 0.0 |
| Gap filling dna repair synthesis and ligation in gg ner 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction assembly 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction degradation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction trafficking and regulation 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gastrin creb signalling pathway via pkc and mapk 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gdp fucose biosynthesis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gene and protein expression by jak stat signaling after interleukin 12 stimulation 1.0 33.0 1.2650510204081633 0.5539124029112868 0.0 0.0 0.0 0.0 |
| Gene silencing by rna 2.0 75.0 1.109027621827981 0.5437935802005475 0.0 0.0 0.0 0.0 |
| Generation of second messenger molecules 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gli proteins bind promoters of hh responsive genes to promote transcription 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Global genome nucleotide excision repair gg ner 1.0 87.0 0.4681537731371618 0.8816275133193132 0.0 0.0 0.0 0.0 |
| Glucagon like peptide 1 glp1 regulates insulin secretion 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon signaling in metabolic regulation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon type ligand receptors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gluconeogenesis 1.0 25.0 1.688095238095238 0.4573561220916043 0.0 0.0 0.0 0.0 |
| Glucose metabolism 3.0 80.0 1.582972582972583 0.3040814280946895 0.0 0.0 0.0 0.0 |
| Glucuronidation 1.0 4.0 10.0 0.0930847686914372 0.0 0.0 0.0 0.0 |
| Glutamate and glutamine metabolism 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutamate neurotransmitter release cycle 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutathione conjugation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutathione synthesis and recycling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycerophospholipid biosynthesis 9.0 86.0 4.869143514713135 0.0002181683579302 0.0 0.0 0.0 0.0 |
| Glycerophospholipid catabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen breakdown glycogenolysis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen metabolism 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen storage diseases 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen synthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycolysis 2.0 66.0 1.2661372950819672 0.4755559518983523 0.0 0.0 0.0 0.0 |
| Glycosaminoglycan metabolism 6.0 70.0 3.86171875 0.0067097031977977 0.0 0.0 0.0 0.0 |
| Glycosphingolipid metabolism 9.0 33.0 10.0 5.5690155596412446e-08 0.0 0.0 0.0 0.0 |
| Glyoxylate metabolism and glycine degradation 1.0 22.0 1.9298347910592808 0.4160065505344545 0.0 0.0 0.0 0.0 |
| Golgi associated vesicle biogenesis 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Golgi cisternae pericentriolar stack reorganization 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Golgi to er retrograde transport 8.0 115.0 3.092122830440588 0.0065981353241554 0.0 0.0 0.0 0.0 |
| Gp1b ix v activation signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gpcr ligand binding 3.0 46.0 2.8443870226815964 0.0989248704147511 0.0 0.0 0.0 0.0 |
| Gpvi mediated activation cascade 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb2 events in erbb2 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb2 sos provides linkage to mapk signaling for integrins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb7 events in erbb2 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Growth hormone receptor signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hats acetylate histones 0.0 90.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hcmv early events 1.0 79.0 0.5165881737310308 0.8558530274917338 0.0 0.0 0.0 0.0 |
| Hcmv infection 1.0 102.0 0.398019801980198 0.918219323141692 0.0 0.0 0.0 0.0 |
| Hcmv late events 1.0 62.0 0.6616928738708598 0.7810312178815177 0.0 0.0 0.0 0.0 |
| Hdacs deacetylate histones 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl assembly 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl clearance 1.0 2.0 10.0 0.0476744094315084 0.0 0.0 0.0 0.0 |
| Hdl remodeling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdms demethylate histones 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through homologous recombination hrr 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through mmej alt nhej 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through single strand annealing ssa 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hedgehog ligand biogenesis 1.0 53.0 0.7769230769230769 0.726859415108312 0.0 0.0 0.0 0.0 |
| Hedgehog off state 1.0 96.0 0.4234156820622986 0.9051756873204616 0.0 0.0 0.0 0.0 |
| Hedgehog on state 1.0 70.0 0.5845016267376516 0.8201241756611954 0.0 0.0 0.0 0.0 |
| Heme biosynthesis 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Heme degradation 2.0 7.0 10.0 0.0112385866308786 0.0 0.0 0.0 0.0 |
| Heme signaling 1.0 36.0 1.156268221574344 0.5855309260576435 0.0 0.0 0.0 0.0 |
| Hemostasis 8.0 361.0 0.9138476920513248 0.6474852901497594 0.0 0.0 0.0 0.0 |
| Heparan sulfate heparin hs gag metabolism 3.0 32.0 4.223499361430396 0.0411512789917762 0.0 0.0 0.0 0.0 |
| Highly calcium permeable nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Histidine catabolism 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hiv elongation arrest and recovery 1.0 32.0 1.3059907834101383 0.5428479192551358 0.0 0.0 0.0 0.0 |
| Hiv infection 3.0 213.0 0.5726043503821282 0.8920486873498326 0.0 0.0 0.0 0.0 |
| Hiv life cycle 2.0 144.0 0.5661510043869776 0.8664690810483541 0.0 0.0 0.0 0.0 |
| Hiv transcription elongation 1.0 42.0 0.986460925833748 0.6422270888991375 0.0 0.0 0.0 0.0 |
| Hiv transcription initiation 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Homologous dna pairing and strand exchange 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Homology directed repair 0.0 106.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Host interactions of hiv factors 2.0 116.0 0.7072188668392292 0.7741771331139926 0.0 0.0 0.0 0.0 |
| Hs gag biosynthesis 1.0 17.0 2.534183673469388 0.3400030327298383 0.0 0.0 0.0 0.0 |
| Hs gag degradation 2.0 17.0 5.42896174863388 0.0621585272883563 0.0 0.0 0.0 0.0 |
| Hsf1 activation 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hsf1 dependent transactivation 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hsp90 chaperone cycle for steroid hormone receptors shr in the presence of ligand 1.0 47.0 0.878793256433008 0.6835238209809511 0.0 0.0 0.0 0.0 |
| Hur elavl1 binds and stabilizes mrna 1.0 7.0 6.764625850340136 0.1571881112173651 0.0 0.0 0.0 0.0 |
| Hyaluronan biosynthesis and export 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan metabolism 1.0 9.0 5.072448979591837 0.1973959389561772 0.0 0.0 0.0 0.0 |
| Hyaluronan uptake and degradation 1.0 8.0 5.797667638483965 0.1775366954381628 0.0 0.0 0.0 0.0 |
| Hydrolysis of lpc 1.0 3.0 10.0 0.0706557803630322 0.0 0.0 0.0 0.0 |
| Ikba variant leads to eda id 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ikk complex recruitment mediated by rip1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Il 6 type cytokine receptor ligand interactions 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Immunoregulatory interactions between a lymphoid and a non lymphoid cell 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inactivation of cdc42 and rac1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inactivation of csf3 g csf signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Incretin synthesis secretion and inactivation 1.0 14.0 3.119937205651492 0.2897526236095206 0.0 0.0 0.0 0.0 |
| Infection with mycobacterium tuberculosis 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Infectious disease 8.0 619.0 0.5137740857390419 0.9847618847229264 0.0 0.0 0.0 0.0 |
| Inflammasomes 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Influenza infection 1.0 150.0 0.2684837693466648 0.9750481923531418 0.0 0.0 0.0 0.0 |
| Inhibition of dna recombination at telomere 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inhibition of replication initiation of damaged dna by rb1 e2f1 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Initial triggering of complement 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Initiation of nuclear envelope ne reformation 4.0 20.0 10.0 0.0011814468070448 0.0 0.0 0.0 0.0 |
| Inla mediated entry of listeria monocytogenes into host cells 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inlb mediated entry of listeria monocytogenes into host cell 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Innate immune system 20.0 624.0 1.3693371622809587 0.1180758276240251 0.0 0.0 0.0 0.0 |
| Inositol phosphate metabolism 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insertion of tail anchored proteins into the endoplasmic reticulum membrane 4.0 19.0 10.0 0.000963248429344 0.0 0.0 0.0 0.0 |
| Insulin processing 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insulin receptor recycling 2.0 15.0 6.265447667087011 0.0495157384890535 0.0 0.0 0.0 0.0 |
| Insulin receptor signalling cascade 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integration of energy metabolism 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integration of provirus 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integrin cell surface interactions 1.0 37.0 1.1240362811791382 0.5955662992954859 0.0 0.0 0.0 0.0 |
| Integrin signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interaction between l1 and ankyrins 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interaction with cumulus cells and the zona pellucida 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interactions of rev with host cellular proteins 1.0 37.0 1.1240362811791382 0.5955662992954859 0.0 0.0 0.0 0.0 |
| Interactions of vpr with host cellular proteins 1.0 37.0 1.1240362811791382 0.5955662992954859 0.0 0.0 0.0 0.0 |
| Interconversion of nucleotide di and triphosphates 1.0 26.0 1.620408163265306 0.4704807306772423 0.0 0.0 0.0 0.0 |
| Interferon alpha beta signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interferon gamma signaling 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interferon signaling 1.0 128.0 0.3156998232363812 0.9569766684544484 0.0 0.0 0.0 0.0 |
| Interleukin 1 family signaling 1.0 95.0 0.4279635258358663 0.9028086877277862 0.0 0.0 0.0 0.0 |
| Interleukin 1 processing 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 1 signaling 1.0 82.0 0.4973041068279163 0.8661154321407631 0.0 0.0 0.0 0.0 |
| Interleukin 10 signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 12 family signaling 1.0 43.0 0.9628765792031098 0.6508948194595567 0.0 0.0 0.0 0.0 |
| Interleukin 12 signaling 1.0 38.0 1.0935466078323222 0.6053596540060717 0.0 0.0 0.0 0.0 |
| Interleukin 15 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 17 signaling 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 2 family signaling 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 2 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 20 family signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 21 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 23 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 27 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 3 interleukin 5 and gm csf signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 35 signalling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 36 pathway 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 37 signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 4 and interleukin 13 signaling 2.0 40.0 2.1380500431406384 0.2511786735203468 0.0 0.0 0.0 0.0 |
| Interleukin 6 family signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 6 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 7 signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 9 signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin receptor shc signaling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intra golgi and retrograde golgi to er traffic 11.0 181.0 2.692866082603254 0.0044088473407 0.0 0.0 0.0 0.0 |
| Intra golgi traffic 2.0 42.0 2.0307377049180326 0.2691814013824262 0.0 0.0 0.0 0.0 |
| Intracellular signaling by second messengers 1.0 233.0 0.1709711470795214 0.9968397647196472 0.0 0.0 0.0 0.0 |
| Intraflagellar transport 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intrinsic pathway for apoptosis 1.0 53.0 0.7769230769230769 0.726859415108312 0.0 0.0 0.0 0.0 |
| Intrinsic pathway of fibrin clot formation 1.0 7.0 6.764625850340136 0.1571881112173651 0.0 0.0 0.0 0.0 |
| Inwardly rectifying k channels 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion channel transport 5.0 82.0 2.6601821415099423 0.0478393395788808 0.0 0.0 0.0 0.0 |
| Ion homeostasis 1.0 31.0 1.349659863945578 0.5315101420828222 0.0 0.0 0.0 0.0 |
| Ion transport by p type atpases 2.0 31.0 2.804126625211984 0.1713585638073601 0.0 0.0 0.0 0.0 |
| Ionotropic activity of kainate receptors 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak1 recruits ikk complex 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak2 mediated activation of tak1 complex 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak4 deficiency tlr2 4 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ire1alpha activates chaperones 6.0 44.0 6.521052631578947 0.0006073886965184 0.0 0.0 0.0 0.0 |
| Irf3 mediated activation of type 1 ifn 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irf3 mediated induction of type i ifn 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Iron uptake and transport 4.0 38.0 4.820612542537676 0.0128293519549119 0.0 0.0 0.0 0.0 |
| Irs activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irs mediated signalling 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Jnk c jun kinases phosphorylation and activation mediated by activated human tak1 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Josephin domain dubs 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate biosynthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate degradation 2.0 6.0 10.0 0.0081566962170519 0.0 0.0 0.0 0.0 |
| Keratan sulfate keratin metabolism 2.0 17.0 5.42896174863388 0.0621585272883563 0.0 0.0 0.0 0.0 |
| Keratinization 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ketone body metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Killing mechanisms 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Kinesins 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ksrp khsrp binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| L1cam interactions 0.0 91.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lagging strand synthesis 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Laminin interactions 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Late endosomal microautophagy 1.0 29.0 1.4463556851311954 0.5079876539292768 0.0 0.0 0.0 0.0 |
| Ldl clearance 1.0 17.0 2.534183673469388 0.3400030327298383 0.0 0.0 0.0 0.0 |
| Ldl remodeling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Leishmania infection 2.0 110.0 0.7469641772920461 0.7482917719536252 0.0 0.0 0.0 0.0 |
| Lgi adam interactions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ligand receptor interactions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Linoleic acid la metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lipid particle organization 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lipophagy 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Listeria monocytogenes entry into host cells 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Long term potentiation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of function of mecp2 in rett syndrome 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of function of smad2 3 in cancer 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of mecp2 binding ability to the ncor smrt complex 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lrr flii interacting protein 1 lrrfip1 activates type i ifn production 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysine catabolism 1.0 11.0 4.057142857142857 0.2356930071839008 0.0 0.0 0.0 0.0 |
| Lysosome vesicle biogenesis 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysosphingolipid and lpa receptors 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| M phase 11.0 355.0 1.307100445324097 0.2389551859995364 0.0 0.0 0.0 0.0 |
| Map2k and mapk activation 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Map3k8 tpl2 dependent mapk1 3 activation 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk family signaling cascades 3.0 212.0 0.5754031543505228 0.8901943754702151 0.0 0.0 0.0 0.0 |
| Mapk targets nuclear events mediated by map kinases 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk1 erk2 activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk3 erk1 activation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk6 mapk4 signaling 1.0 77.0 0.5302900107411386 0.8485799055650284 0.0 0.0 0.0 0.0 |
| Mastl facilitates mitotic progression 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of protein 3a 1.0 5.0 10.0 0.1149745986461117 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 1 nucleoprotein 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 1 spike protein 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 2 nucleoprotein 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 2 spike protein 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates neuronal receptors and channels 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates transcription factors 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates transcription of neuronal ligands 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Meiosis 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Meiotic recombination 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Meiotic synapsis 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Membrane trafficking 14.0 532.0 1.0987884436160298 0.4080680546662839 0.0 0.0 0.0 0.0 |
| Met activates pi3k akt signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ptk2 signaling 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ptpn11 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates rap1 and rac1 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ras signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met interacts with tns proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met promotes cell motility 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met receptor activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met receptor recycling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolic disorders of biological oxidation enzymes 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of amine derived hormones 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of amino acids and derivatives 6.0 281.0 0.8795454545454545 0.6765947016729961 0.0 0.0 0.0 0.0 |
| Metabolism of angiotensinogen to angiotensins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of carbohydrates 9.0 201.0 1.9299841772151896 0.054602117773195 0.0 0.0 0.0 0.0 |
| Metabolism of cofactors 1.0 15.0 2.896793002915452 0.3069124011154697 0.0 0.0 0.0 0.0 |
| Metabolism of fat soluble vitamins 1.0 29.0 1.4463556851311954 0.5079876539292768 0.0 0.0 0.0 0.0 |
| Metabolism of folate and pterines 2.0 15.0 6.265447667087011 0.0495157384890535 0.0 0.0 0.0 0.0 |
| Metabolism of ingested semet sec mesec into h2se 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of lipids 40.0 508.0 3.93411335158908 2.3537908553383934e-11 0.0 0.0 0.0 0.0 |
| Metabolism of nitric oxide nos3 activation and regulation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of nucleotides 2.0 82.0 1.0112704918032789 0.592458577023541 0.0 0.0 0.0 0.0 |
| Metabolism of polyamines 1.0 48.0 0.8600086843247937 0.6911948368646196 0.0 0.0 0.0 0.0 |
| Metabolism of porphyrins 3.0 17.0 8.761904761904763 0.0073447144383531 0.0 0.0 0.0 0.0 |
| Metabolism of rna 5.0 647.0 0.3007975594938017 0.9996419105096468 0.0 0.0 0.0 0.0 |
| Metabolism of steroid hormones 2.0 12.0 8.147540983606557 0.032628233248221 0.0 0.0 0.0 0.0 |
| Metabolism of steroids 12.0 103.0 5.555931248238941 6.51109102422212e-06 0.0 0.0 0.0 0.0 |
| Metabolism of vitamins and cofactors 4.0 134.0 1.2485696122059755 0.4057604474152967 0.0 0.0 0.0 0.0 |
| Metabolism of water soluble vitamins and cofactors 3.0 91.0 1.3835578002244668 0.3769372615021911 0.0 0.0 0.0 0.0 |
| Metal ion slc transporters 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metalloprotease dubs 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metallothioneins bind metals 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Methionine salvage pathway 1.0 6.0 8.118367346938776 0.1363381791325428 0.0 0.0 0.0 0.0 |
| Methylation 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Mhc class ii antigen presentation 2.0 100.0 0.8240214118434259 0.6995311108717109 0.0 0.0 0.0 0.0 |
| Microrna mirna biogenesis 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miro gtpase cycle 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miscellaneous substrates 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miscellaneous transport and binding events 1.0 17.0 2.534183673469388 0.3400030327298383 0.0 0.0 0.0 0.0 |
| Mismatch repair 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial biogenesis 5.0 85.0 2.559647302904564 0.0543296939149059 0.0 0.0 0.0 0.0 |
| Mitochondrial calcium ion transport 5.0 21.0 10.0 0.0001164002838048 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation of saturated fatty acids 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation of unsaturated fatty acids 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial iron sulfur cluster biogenesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial protein import 8.0 59.0 6.524303839182732 7.846229983304866e-05 0.0 0.0 0.0 0.0 |
| Mitochondrial translation 1.0 93.0 0.4373558118899733 0.8978967157475708 0.0 0.0 0.0 0.0 |
| Mitochondrial trna aminoacylation 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial uncoupling 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitophagy 3.0 24.0 5.837154614932393 0.0193169154759243 0.0 0.0 0.0 0.0 |
| Mitotic g1 phase and g1 s transition 3.0 143.0 0.8650793650793651 0.675105434500062 0.0 0.0 0.0 0.0 |
| Mitotic g2 g2 m phases 5.0 186.0 1.1197588317553473 0.4674992756463298 0.0 0.0 0.0 0.0 |
| Mitotic metaphase and anaphase 6.0 225.0 1.1108447488584474 0.4604909851804931 0.0 0.0 0.0 0.0 |
| Mitotic prometaphase 4.0 198.0 0.8312175172531311 0.7082637951653802 0.0 0.0 0.0 0.0 |
| Mitotic prophase 4.0 93.0 1.831367815024608 0.1867445382627056 0.0 0.0 0.0 0.0 |
| Mitotic spindle checkpoint 0.0 111.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitotic telophase cytokinesis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Modulation by mtb of host immune system 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Molecules associated with elastic fibres 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Molybdenum cofactor biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna capping 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna decay by 3 to 5 exoribonuclease 1.0 16.0 2.703401360544217 0.3236592382947187 0.0 0.0 0.0 0.0 |
| Mrna decay by 5 to 3 exoribonuclease 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna editing 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna editing c to u conversion 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna splicing 1.0 188.0 0.213096147549929 0.99029070986525 0.0 0.0 0.0 0.0 |
| Mrna splicing minor pathway 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mtor signalling 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mtorc1 mediated signalling 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mucopolysaccharidoses 2.0 9.0 10.0 0.0186627473263165 0.0 0.0 0.0 0.0 |
| Multifunctional anion exchangers 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Muscle contraction 2.0 83.0 0.9986844768265534 0.5990875991193605 0.0 0.0 0.0 0.0 |
| Myd88 independent tlr4 cascade 0.0 78.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Myoclonic epilepsy of lafora 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Myogenesis 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan antennae elongation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan antennae elongation in the medial trans golgi 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan trimming and elongation in the cis golgi 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan trimming in the er and calnexin calreticulin cycle 1.0 32.0 1.3059907834101383 0.5428479192551358 0.0 0.0 0.0 0.0 |
| Na cl dependent neurotransmitter transporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nade modulates death signalling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ncam signaling for neurite out growth 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ncam1 interactions 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nectin necl trans heterodimerization 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neddylation 1.0 185.0 0.216637089618456 0.9895382003402328 0.0 0.0 0.0 0.0 |
| Nef and signal transduction 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated cd4 down regulation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated cd8 down regulation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated downregulation of mhc class i complex cell surface expression 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediates down modulation of cell surface receptors by recruiting them to clathrin adapters 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative epigenetic regulation of rrna expression 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative feedback regulation of mapk pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of activity of tfap2 ap 2 family transcription factors 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr1 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr2 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr3 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr4 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of flt3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of mapk pathway 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of met activity 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of nmda receptor mediated neuronal transmission 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of notch4 signaling 1.0 49.0 0.8420068027210884 0.6986806537780095 0.0 0.0 0.0 0.0 |
| Negative regulation of tcf dependent signaling by dvl interacting proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of tcf dependent signaling by wnt ligand antagonists 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of the pi3k akt network 0.0 62.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulators of ddx58 ifih1 signaling 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nephrin family interactions 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nervous system development 3.0 443.0 0.2668350168350168 0.9987822676196296 0.0 0.0 0.0 0.0 |
| Netrin 1 signaling 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Netrin mediated repulsion signals 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurexins and neuroligins 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurofascin interactions 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neuronal system 2.0 177.0 0.4578454332552693 0.9303703820442676 0.0 0.0 0.0 0.0 |
| Neurotoxicity of clostridium toxins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter clearance 1.0 3.0 10.0 0.0706557803630322 0.0 0.0 0.0 0.0 |
| Neurotransmitter receptors and postsynaptic signal transmission 0.0 105.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter release cycle 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neutrophil degranulation 15.0 319.0 2.060406698564593 0.0104534281651405 0.0 0.0 0.0 0.0 |
| Nf kb activation through fadd rip 1 pathway mediated by caspase 8 and 10 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nf kb is activated and signals survival 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ngf independant trka activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ngf stimulated transcription 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nicotinamide salvaging 1.0 11.0 4.057142857142857 0.2356930071839008 0.0 0.0 0.0 0.0 |
| Nicotinate metabolism 1.0 18.0 2.384873949579832 0.3559534457378639 0.0 0.0 0.0 0.0 |
| Nitric oxide stimulates guanylate cyclase 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nod1 2 signaling pathway 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Non integrin membrane ecm interactions 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Noncanonical activation of notch3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nonhomologous end joining nhej 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nonsense mediated decay nmd 0.0 110.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Norepinephrine neurotransmitter release cycle 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nostrin mediated enos trafficking 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch hlh transcription pathway 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch1 intracellular domain regulates transcription 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch2 activation and transmission of signal to the nucleus 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch2 intracellular domain regulates transcription 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch3 activation and transmission of signal to the nucleus 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch3 intracellular domain regulates transcription 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch4 activation and transmission of signal to the nucleus 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch4 intracellular domain regulates transcription 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 and nr1h3 mediated signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to gluconeogenesis 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to lipogenesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to triglyceride lipolysis in adipose 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression to control bile acid homeostasis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression to limit cholesterol uptake 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h3 nr1h2 regulate gene expression linked to cholesterol transport and efflux 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrage signals death through jnk 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrcam interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrif signals cell death from the nucleus 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ns1 mediated effects on host pathways 1.0 40.0 1.037257980115123 0.6242434222626774 0.0 0.0 0.0 0.0 |
| Ntrk2 activates rac1 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear envelope breakdown 3.0 54.0 2.3962720890825464 0.1411134338084059 0.0 0.0 0.0 0.0 |
| Nuclear envelope ne reassembly 5.0 71.0 3.1070036464227337 0.02815445047553 0.0 0.0 0.0 0.0 |
| Nuclear events kinase and transcription factor activation 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear events stimulated by alk signaling in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear import of rev protein 1.0 34.0 1.2265924551638838 0.5647101544543685 0.0 0.0 0.0 0.0 |
| Nuclear pore complex npc disassembly 1.0 36.0 1.156268221574344 0.5855309260576435 0.0 0.0 0.0 0.0 |
| Nuclear receptor transcription pathway 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear signaling by erbb4 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide binding domain leucine rich repeat containing receptor nlr signaling pathways 1.0 42.0 0.986460925833748 0.6422270888991375 0.0 0.0 0.0 0.0 |
| Nucleotide biosynthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide catabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide excision repair 1.0 114.0 0.3553187646740112 0.939186977811998 0.0 0.0 0.0 0.0 |
| Nucleotide like purinergic receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide salvage 1.0 20.0 2.133404940923738 0.3867116248199588 0.0 0.0 0.0 0.0 |
| O glycosylation of tsr domain containing proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| O linked glycosylation 1.0 35.0 1.190396158463385 0.5752475783862557 0.0 0.0 0.0 0.0 |
| O linked glycosylation of mucins 1.0 22.0 1.9298347910592808 0.4160065505344545 0.0 0.0 0.0 0.0 |
| Oas antiviral response 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Olfactory signaling pathway 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oncogene induced senescence 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oncogenic mapk signaling 1.0 66.0 0.6207221350078493 0.8015340371466311 0.0 0.0 0.0 0.0 |
| Opioid signalling 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Orc1 removal from chromatin 2.0 65.0 1.2863648191517043 0.4675997956478902 0.0 0.0 0.0 0.0 |
| Organelle biogenesis and maintenance 12.0 268.0 1.9419070512820515 0.0291492250803966 0.0 0.0 0.0 0.0 |
| Organic anion transporters 1.0 3.0 10.0 0.0706557803630322 0.0 0.0 0.0 0.0 |
| Organic cation anion zwitterion transport 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Organic cation transport 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Other interleukin signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Other semaphorin interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ovarian tumor domain proteases 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oxidative stress induced senescence 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P130cas linkage to mapk signaling for integrins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P2y receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P38mapk events 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75 ntr receptor mediated signalling 1.0 81.0 0.5035714285714286 0.8627781534140635 0.0 0.0 0.0 0.0 |
| P75ntr negatively regulates cell cycle via sc1 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr recruits signalling complexes 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr regulates axonogenesis 1.0 5.0 10.0 0.1149745986461117 0.0 0.0 0.0 0.0 |
| P75ntr signals via nf kb 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Parasite infection 1.0 50.0 0.8247396917950853 0.705985725150242 0.0 0.0 0.0 0.0 |
| Passive transport by aquaporins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pcna dependent long patch base excision repair 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pcp ce pathway 1.0 78.0 0.5233501192684866 0.8522610344387342 0.0 0.0 0.0 0.0 |
| Pd 1 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pecam1 interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pentose phosphate pathway 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Peptide hormone metabolism 1.0 43.0 0.9628765792031098 0.6508948194595567 0.0 0.0 0.0 0.0 |
| Peptide ligand binding receptors 3.0 17.0 8.761904761904763 0.0073447144383531 0.0 0.0 0.0 0.0 |
| Perk regulates gene expression 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Peroxisomal lipid metabolism 1.0 24.0 1.7616681455190772 0.4439075633632242 0.0 0.0 0.0 0.0 |
| Peroxisomal protein import 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pexophagy 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 0 rapid depolarisation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 2 plateau phase 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 3 rapid repolarisation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 4 resting membrane potential 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase i functionalization of compounds 4.0 39.0 4.682408500590319 0.0140312853386763 0.0 0.0 0.0 0.0 |
| Phase ii conjugation of compounds 3.0 53.0 2.4444444444444446 0.135543868878084 0.0 0.0 0.0 0.0 |
| Phenylalanine and tyrosine metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phenylalanine metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphate bond hydrolysis by ntpdase proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphate bond hydrolysis by nudt proteins 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipase c mediated cascade fgfr2 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipase c mediated cascade fgfr4 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipid metabolism 10.0 156.0 2.845368005572324 0.0044922754835291 0.0 0.0 0.0 0.0 |
| Phosphorylation of emi1 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphorylation of the apc c 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Physiological factors 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr2 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr4 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi metabolism 1.0 71.0 0.5760932944606414 0.8244940603927083 0.0 0.0 0.0 0.0 |
| Pi3k akt activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k akt signaling in cancer 0.0 58.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k events in erbb2 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k events in erbb4 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi5p regulates tp53 acetylation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pink1 prkn mediated mitophagy 3.0 17.0 8.761904761904763 0.0073447144383531 0.0 0.0 0.0 0.0 |
| Piwi interacting rna pirna biogenesis 1.0 16.0 2.703401360544217 0.3236592382947187 0.0 0.0 0.0 0.0 |
| Pka activation in glucagon signalling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka mediated phosphorylation of creb 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka mediated phosphorylation of key metabolic factors 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pkmts methylate histone lysines 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein assembly 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein assembly remodeling and clearance 2.0 40.0 2.1380500431406384 0.2511786735203468 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein clearance 2.0 23.0 3.875487900078064 0.1053546389470493 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein remodeling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet activation signaling and aggregation 5.0 152.0 1.3835492703305388 0.305155459734769 0.0 0.0 0.0 0.0 |
| Platelet adhesion to exposed collagen 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet aggregation plug formation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet calcium homeostasis 1.0 13.0 3.380272108843537 0.2721697661507766 0.0 0.0 0.0 0.0 |
| Platelet homeostasis 1.0 51.0 0.8081632653061225 0.713114397687874 0.0 0.0 0.0 0.0 |
| Platelet sensitization by ldl 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polb dependent long patch base excision repair 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polo like kinase mediated events 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polymerase switching 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polymerase switching on the c strand of the telomere 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Positive epigenetic regulation of rrna expression 0.0 60.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post chaperonin tubulin folding pathway 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post translational modification synthesis of gpi anchored proteins 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post translational protein modification 25.0 1003.0 1.0377629107329576 0.4630736069626939 0.0 0.0 0.0 0.0 |
| Postmitotic nuclear pore complex npc reformation 1.0 27.0 1.5579277864992152 0.4832891613764908 0.0 0.0 0.0 0.0 |
| Potassium channels 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Potential therapeutics for sars 2.0 68.0 1.2275211127670145 0.4912505524209553 0.0 0.0 0.0 0.0 |
| Pou5f1 oct4 sox2 nanog activate genes related to proliferation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pou5f1 oct4 sox2 nanog repress genes related to differentiation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pp2a mediated dephosphorylation of key metabolic factors 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prc2 methylates histones and dna 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch expression and processing 2.0 50.0 1.690915300546448 0.3407321567572847 0.0 0.0 0.0 0.0 |
| Pre notch processing in golgi 2.0 13.0 7.406110283159464 0.0379575415698398 0.0 0.0 0.0 0.0 |
| Pre notch processing in the endoplasmic reticulum 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pregnenolone biosynthesis 2.0 8.0 10.0 0.0147480216610697 0.0 0.0 0.0 0.0 |
| Presynaptic depolarization and calcium channel opening 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic function of kainate receptors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prevention of phagosomal lysosomal fusion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing and activation of sumo 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of capped intron containing pre mrna 2.0 239.0 0.3359272324825344 0.980814407041362 0.0 0.0 0.0 0.0 |
| Processing of capped intronless pre mrna 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of dna double strand break ends 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of intronless pre mrnas 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of smdt1 1.0 16.0 2.703401360544217 0.3236592382947187 0.0 0.0 0.0 0.0 |
| Processive synthesis on the c strand of the telomere 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processive synthesis on the lagging strand 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Programmed cell death 3.0 179.0 0.6856060606060606 0.8110162953932397 0.0 0.0 0.0 0.0 |
| Prolactin receptor signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prolonged erk activation events 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Propionyl coa catabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prostacyclin signalling through prostacyclin receptor 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein folding 1.0 79.0 0.5165881737310308 0.8558530274917338 0.0 0.0 0.0 0.0 |
| Protein localization 14.0 142.0 4.630522629310345 8.048807489365991e-06 0.0 0.0 0.0 0.0 |
| Protein methylation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein protein interactions at synapses 1.0 46.0 0.8984126984126984 0.6756630435254583 0.0 0.0 0.0 0.0 |
| Protein repair 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein ubiquitination 1.0 58.0 0.7084138918725384 0.7584198129875613 0.0 0.0 0.0 0.0 |
| Proton coupled monocarboxylate transport 1.0 4.0 10.0 0.0930847686914372 0.0 0.0 0.0 0.0 |
| Pten regulation 1.0 128.0 0.3156998232363812 0.9569766684544484 0.0 0.0 0.0 0.0 |
| Ptk6 expression 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 promotes hif1a stabilization 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates cell cycle 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates proteins involved in rna processing 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates rho gtpases ras gtpase and map kinases 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates rtks and their effectors akt1 and dok1 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine catabolism 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine ribonucleoside monophosphate biosynthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine salvage 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Purinergic signaling in leishmaniasis infection 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Pyrimidine catabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyrimidine salvage 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyroptosis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyruvate metabolism 2.0 26.0 3.3900273224043715 0.1292409073430241 0.0 0.0 0.0 0.0 |
| Pyruvate metabolism and citric acid tca cycle 3.0 48.0 2.7174211248285323 0.1089349903226686 0.0 0.0 0.0 0.0 |
| Ra biosynthesis pathway 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rab gefs exchange gtp for gdp on rabs 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rab geranylgeranylation 1.0 54.0 0.762187139006546 0.7334839427632852 0.0 0.0 0.0 0.0 |
| Rab regulation of trafficking 0.0 107.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rac1 gtpase cycle 4.0 152.0 1.0947062765244584 0.5017438758479931 0.0 0.0 0.0 0.0 |
| Rac2 gtpase cycle 6.0 81.0 3.2916666666666665 0.0133560961650828 0.0 0.0 0.0 0.0 |
| Rac3 gtpase cycle 5.0 83.0 2.6258112565166507 0.0499487852123864 0.0 0.0 0.0 0.0 |
| Raf activation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Raf independent mapk1 3 activation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rap1 signalling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ras activation upon ca2 influx through nmda receptor 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ras processing 2.0 19.0 4.789296046287367 0.0757571260003459 0.0 0.0 0.0 0.0 |
| Ras signaling downstream of nf1 loss of function variants 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reactions specific to the complex n glycan synthesis pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Receptor mediated mitophagy 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Receptor type tyrosine protein phosphatases 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recognition and association of dna glycosylase with site containing an affected purine 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recognition of dna damage by pcna containing replication complex 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recruitment of mitotic centrosome proteins and complexes 4.0 82.0 2.0919686374231827 0.1360002203186876 0.0 0.0 0.0 0.0 |
| Recruitment of numa to mitotic centrosomes 4.0 90.0 1.8958293292331347 0.1723284412806655 0.0 0.0 0.0 0.0 |
| Recycling of bile acids and salts 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling of eif2 gdp 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling pathway of l1 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reduction of cytosolic ca levels 1.0 7.0 6.764625850340136 0.1571881112173651 0.0 0.0 0.0 0.0 |
| Reelin signalling pathway 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulated necrosis 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulated proteolysis of p75ntr 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation by c flip 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of bach1 activity 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of beta cell development 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of cholesterol biosynthesis by srebp srebf 4.0 55.0 3.208232053151839 0.0432632841258681 0.0 0.0 0.0 0.0 |
| Regulation of commissural axon pathfinding by slit and robo 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of cytoskeletal remodeling and cell spreading by ipp complex components 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of expression of slits and robos 1.0 155.0 0.2596342433077127 0.9779577629651784 0.0 0.0 0.0 0.0 |
| Regulation of foxo transcriptional activity by acetylation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of fzd by ubiquitination 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression by hypoxia inducible factor 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in beta cells 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in early pancreatic precursor cells 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in late stage branching morphogenesis pancreatic bud precursor cells 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of glucokinase by glucokinase regulatory protein 1.0 31.0 1.349659863945578 0.5315101420828222 0.0 0.0 0.0 0.0 |
| Regulation of glycolysis by fructose 2 6 bisphosphate metabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of hmox1 expression and activity 3.0 58.0 2.221099887766554 0.1641182363781922 0.0 0.0 0.0 0.0 |
| Regulation of hsf1 mediated heat shock response 1.0 76.0 0.5374149659863946 0.8448074381544391 0.0 0.0 0.0 0.0 |
| Regulation of ifna signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of ifng signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of innate immune responses to cytosolic dna 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of insulin like growth factor igf transport and uptake by insulin like growth factor binding proteins igfbps 3.0 56.0 2.305380852550664 0.1524764865133537 0.0 0.0 0.0 0.0 |
| Regulation of insulin secretion 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of kit signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of lipid metabolism by pparalpha 2.0 95.0 0.868764322228098 0.6723540440907236 0.0 0.0 0.0 0.0 |
| Regulation of localization of foxo transcription factors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of mecp2 expression and activity 1.0 30.0 1.3963406052076002 0.5198923492291299 0.0 0.0 0.0 0.0 |
| Regulation of mrna stability by proteins that bind au rich elements 2.0 79.0 1.0509899936129443 0.5720855777628291 0.0 0.0 0.0 0.0 |
| Regulation of plk1 activity at g2 m transition 4.0 87.0 1.964950711938664 0.1583244338759907 0.0 0.0 0.0 0.0 |
| Regulation of pten gene transcription 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten localization 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten mrna translation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten stability and activity 1.0 63.0 0.6509545753785385 0.7863466234909413 0.0 0.0 0.0 0.0 |
| Regulation of pyruvate dehydrogenase pdh complex 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of ras by gaps 1.0 57.0 0.7211370262390671 0.7524126639072135 0.0 0.0 0.0 0.0 |
| Regulation of runx1 expression and activity 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of runx2 expression and activity 1.0 61.0 0.6727891156462585 0.7755841231055027 0.0 0.0 0.0 0.0 |
| Regulation of runx3 expression and activity 1.0 52.0 0.7922368947579032 0.7200709140128994 0.0 0.0 0.0 0.0 |
| Regulation of signaling by cbl 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of signaling by nodal 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tlr by endogenous ligand 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tnfr1 signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity 0.0 146.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through acetylation 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through association with co factors 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through methylation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through phosphorylation 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 expression and degradation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Release of apoptotic factors from the mitochondria 1.0 6.0 8.118367346938776 0.1363381791325428 0.0 0.0 0.0 0.0 |
| Release of hh np from the secreting cell 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Removal of aminoterminal propeptides from gamma carboxylated proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Repression of wnt target genes 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reproduction 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of abasic sites ap sites 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of ap sites via the multiple nucleotide patch replacement pathway 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of d loop structures 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of d loop structures through synthesis dependent strand annealing sdsa 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of sister chromatid cohesion 0.0 120.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Respiratory electron transport 9.0 101.0 4.069069895432031 0.000724477579467 0.0 0.0 0.0 0.0 |
| Respiratory electron transport atp synthesis by chemiosmotic coupling and heat production by uncoupling proteins 12.0 116.0 4.855029585798817 2.219928302633049e-05 0.0 0.0 0.0 0.0 |
| Response of eif2ak1 hri to heme deficiency 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response of eif2ak4 gcn2 to amino acid deficiency 0.0 94.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response of mtb to phagocytosis 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response to elevated platelet cytosolic ca2 5.0 71.0 3.1070036464227337 0.02815445047553 0.0 0.0 0.0 0.0 |
| Response to metal ions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ret signaling 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retinoid cycle disease events 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retrograde neurotrophin signalling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retrograde transport at the trans golgi network 1.0 49.0 0.8420068027210884 0.6986806537780095 0.0 0.0 0.0 0.0 |
| Reversible hydration of carbon dioxide 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpase cycle 13.0 387.0 1.42856487112988 0.1432657514104712 0.0 0.0 0.0 0.0 |
| Rho gtpase effectors 1.0 246.0 0.1616826322365681 0.9977171351381026 0.0 0.0 0.0 0.0 |
| Rho gtpases activate cit 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate formins 0.0 133.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate iqgaps 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate ktn1 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate nadph oxidases 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate paks 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate pkns 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate rhotekin and rhophilins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate rocks 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate wasps and waves 1.0 33.0 1.2650510204081633 0.5539124029112868 0.0 0.0 0.0 0.0 |
| Rhoa gtpase cycle 5.0 134.0 1.5794975714883075 0.2226406444315481 0.0 0.0 0.0 0.0 |
| Rhob gtpase cycle 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb gtpase cycle 1.0 33.0 1.2650510204081633 0.5539124029112868 0.0 0.0 0.0 0.0 |
| Rhobtb1 gtpase cycle 1.0 22.0 1.9298347910592808 0.4160065505344545 0.0 0.0 0.0 0.0 |
| Rhobtb2 gtpase cycle 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb3 atpase cycle 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoc gtpase cycle 2.0 75.0 1.109027621827981 0.5437935802005475 0.0 0.0 0.0 0.0 |
| Rhod gtpase cycle 4.0 50.0 3.5587495508444125 0.03203241935523 0.0 0.0 0.0 0.0 |
| Rhof gtpase cycle 1.0 42.0 0.986460925833748 0.6422270888991375 0.0 0.0 0.0 0.0 |
| Rhog gtpase cycle 6.0 71.0 3.8019230769230767 0.0071849444758907 0.0 0.0 0.0 0.0 |
| Rhoh gtpase cycle 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoj gtpase cycle 1.0 55.0 0.7479969765684051 0.7399484418736413 0.0 0.0 0.0 0.0 |
| Rhoq gtpase cycle 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhot1 gtpase cycle 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhou gtpase cycle 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhov gtpase cycle 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rip mediated nfkb activation via zbp1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ripk1 mediated regulated necrosis 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rmts methylate histone arginines 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i promoter escape 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription initiation 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription termination 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcribes snrna genes 0.0 73.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcription 6.0 969.0 0.2333073727933541 0.9999980054230893 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcription termination 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii chain elongation 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription initiation from type 1 promoter 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription initiation from type 3 promoter 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription termination 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rnd1 gtpase cycle 1.0 36.0 1.156268221574344 0.5855309260576435 0.0 0.0 0.0 0.0 |
| Rnd2 gtpase cycle 2.0 40.0 2.1380500431406384 0.2511786735203468 0.0 0.0 0.0 0.0 |
| Rnd3 gtpase cycle 1.0 39.0 1.0646616541353384 0.6149168035506691 0.0 0.0 0.0 0.0 |
| Robo receptors bind akap5 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of abl in robo slit signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of lat2 ntal lab on calcium mobilization 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of phospholipids in phagocytosis 1.0 16.0 2.703401360544217 0.3236592382947187 0.0 0.0 0.0 0.0 |
| Role of second messengers in netrin 1 signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rora activates gene expression 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ros and rns production in phagocytes 2.0 16.0 5.817330210772834 0.0557098434243155 0.0 0.0 0.0 0.0 |
| Rrna modification in the mitochondrion 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna modification in the nucleus and cytosol 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna processing 0.0 202.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna processing in the mitochondrion 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rsk activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 and foxp3 control the development of regulatory t lymphocytes tregs 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 interacts with co factors whose precise effect on runx1 targets is not known 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates estrogen receptor mediated transcription 1.0 5.0 10.0 0.1149745986461117 0.0 0.0 0.0 0.0 |
| Runx1 regulates expression of components of tight junctions 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates genes involved in megakaryocyte differentiation and platelet function 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in bcr signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of hscs 1.0 68.0 0.6020712762717028 0.8110566761636493 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of keratinocytes 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of myeloid cells 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in interleukin signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in wnt signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates bone development 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates chondrocyte maturation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates genes involved in cell migration 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates osteoblast differentiation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates bcl2l11 bim transcription 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates cdkn1a transcription 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates immune response and cell migration 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates notch signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates p14 arf 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates wnt signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates yap1 mediated transcription 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| S phase 2.0 158.0 0.5146069777217318 0.898328295774439 0.0 0.0 0.0 0.0 |
| Sars cov 1 infection 1.0 42.0 0.986460925833748 0.6422270888991375 0.0 0.0 0.0 0.0 |
| Sars cov 2 infection 1.0 62.0 0.6616928738708598 0.7810312178815177 0.0 0.0 0.0 0.0 |
| Sars cov infections 3.0 128.0 0.9703703703703704 0.6006618364793616 0.0 0.0 0.0 0.0 |
| Scavenging by class a receptors 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging by class b receptors 1.0 2.0 10.0 0.0476744094315084 0.0 0.0 0.0 0.0 |
| Scavenging by class f receptors 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging of heme from plasma 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scf skp2 mediated degradation of p27 p21 1.0 54.0 0.762187139006546 0.7334839427632852 0.0 0.0 0.0 0.0 |
| Sealing of the nuclear envelope ne by escrt iii 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Selective autophagy 4.0 67.0 2.5939918667191395 0.0780890051531907 0.0 0.0 0.0 0.0 |
| Selenoamino acid metabolism 0.0 107.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema3a pak dependent axon repulsion 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema3a plexin repulsion signaling by inhibiting integrin adhesion 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d in semaphorin signaling 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d induced cell migration and growth cone collapse 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d mediated inhibition of cell attachment and migration 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Semaphorin interactions 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Senescence associated secretory phenotype sasp 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensing of dna double strand breaks 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory perception 0.0 84.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory perception of taste 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory processing of sound 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory processing of sound by outer hair cells of the cochlea 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Separation of sister chromatids 1.0 179.0 0.2240770465489566 0.987854518387464 0.0 0.0 0.0 0.0 |
| Serine biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Serotonin neurotransmitter release cycle 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr4 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc related events triggered by igf1r 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in egfr signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in erbb2 signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in erbb4 signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sialic acid metabolism 2.0 16.0 5.817330210772834 0.0557098434243155 0.0 0.0 0.0 0.0 |
| Signal amplification 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal attenuation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal regulatory protein family interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal transduction by l1 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by activin 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by alk 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by alk in cancer 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by bmp 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by braf and raf1 fusions 1.0 53.0 0.7769230769230769 0.726859415108312 0.0 0.0 0.0 0.0 |
| Signaling by csf3 g csf 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ctnnb1 phospho site mutants 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by cytosolic fgfr1 fusion mutants 1.0 18.0 2.384873949579832 0.3559534457378639 0.0 0.0 0.0 0.0 |
| Signaling by egfr 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by egfr in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 ecd mutants 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb4 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erythropoietin 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr in disease 1.0 48.0 0.8600086843247937 0.6911948368646196 0.0 0.0 0.0 0.0 |
| Signaling by fgfr1 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr1 in disease 1.0 29.0 1.4463556851311954 0.5079876539292768 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 iiia tm 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 in disease 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr3 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr3 fusions in cancer 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr4 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr4 in disease 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by flt3 fusion proteins 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by flt3 itd and tkd mutants 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by gpcr 3.0 204.0 0.5987961427430748 0.87431117648574 0.0 0.0 0.0 0.0 |
| Signaling by hedgehog 1.0 122.0 0.3315567549333783 0.9500953491287616 0.0 0.0 0.0 0.0 |
| Signaling by hippo 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by insulin receptor 2.0 45.0 1.8884864658787648 0.2961580697833918 0.0 0.0 0.0 0.0 |
| Signaling by interleukins 4.0 248.0 0.6574989838775234 0.853844801780807 0.0 0.0 0.0 0.0 |
| Signaling by kit in disease 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by leptin 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by lrp5 mutants 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mapk mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by membrane tethered fusions of pdgfra or pdgfrb 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by met 0.0 64.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by moderate kinase activity braf mutants 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mras complex mutants 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mst1 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by nodal 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch 3.0 152.0 0.8120805369127517 0.714626429470328 0.0 0.0 0.0 0.0 |
| Signaling by notch1 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 hd domain mutants in cancer 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 pest domain mutants in cancer 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 t 7 9 notch1 m1580 k2555 translocation mutant 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch2 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch3 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch4 1.0 71.0 0.5760932944606414 0.8244940603927083 0.0 0.0 0.0 0.0 |
| Signaling by ntrk2 trkb 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrk3 trkc 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrks 0.0 102.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by nuclear receptors 1.0 178.0 0.2253660786348437 0.9875487684200608 0.0 0.0 0.0 0.0 |
| Signaling by pdgf 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by pdgfr in disease 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by pdgfra transmembrane juxtamembrane and kinase domain mutants 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ptk6 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by receptor tyrosine kinases 3.0 344.0 0.347887476919735 0.9906261361507251 0.0 0.0 0.0 0.0 |
| Signaling by retinoic acid 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by rho gtpases miro gtpases and rhobtb3 13.0 593.0 0.9013615509841646 0.6802819208492408 0.0 0.0 0.0 0.0 |
| Signaling by rnf43 mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by robo receptors 1.0 197.0 0.2031236984589754 0.9922398226180882 0.0 0.0 0.0 0.0 |
| Signaling by scf kit 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgf beta receptor complex 0.0 67.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgf beta receptor complex in cancer 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgfb family members 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by the b cell receptor bcr 1.0 91.0 0.4471655328798186 0.8927375563642727 0.0 0.0 0.0 0.0 |
| Signaling by type 1 insulin like growth factor 1 receptor igf1r 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by vegf 1.0 87.0 0.4681537731371618 0.8816275133193132 0.0 0.0 0.0 0.0 |
| Signaling by wnt 1.0 213.0 0.1874855602618405 0.9947922929961756 0.0 0.0 0.0 0.0 |
| Signaling by wnt in cancer 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to erks 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to p38 via rit and rin 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to ras 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sirt1 negatively regulates rrna expression 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Slbp dependent processing of replication dependent histone pre mrnas 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Slc mediated transmembrane transport 5.0 101.0 2.129581604426003 0.0970705055296173 0.0 0.0 0.0 0.0 |
| Slc transporter disorders 2.0 54.0 1.5602143757881464 0.3757594500595086 0.0 0.0 0.0 0.0 |
| Smac xiap regulated apoptotic response 1.0 8.0 5.797667638483965 0.1775366954381628 0.0 0.0 0.0 0.0 |
| Smad2 smad3 smad4 heterotrimer regulates transcription 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Small interfering rna sirna biogenesis 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Smooth muscle contraction 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Snrnp assembly 1.0 53.0 0.7769230769230769 0.726859415108312 0.0 0.0 0.0 0.0 |
| Sodium calcium exchangers 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium coupled phosphate cotransporters 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium proton exchangers 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sos mediated signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sperm motility and taxes 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sphingolipid de novo biosynthesis 5.0 29.0 8.580567081604427 0.0005802452812718 0.0 0.0 0.0 0.0 |
| Sphingolipid metabolism 14.0 62.0 10.0 1.624996215231168e-10 0.0 0.0 0.0 0.0 |
| Spry regulation of fgf signaling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Srp dependent cotranslational protein targeting to membrane 4.0 108.0 1.5648442466624284 0.2636844736780806 0.0 0.0 0.0 0.0 |
| Stabilization of p53 1.0 51.0 0.8081632653061225 0.713114397687874 0.0 0.0 0.0 0.0 |
| Stat3 nuclear events downstream of alk signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat5 activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat5 activation downstream of flt3 itd mutants 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stimuli sensing channels 1.0 38.0 1.0935466078323222 0.6053596540060717 0.0 0.0 0.0 0.0 |
| Sting mediated induction of host immune responses 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Striated muscle contraction 1.0 16.0 2.703401360544217 0.3236592382947187 0.0 0.0 0.0 0.0 |
| Sulfide oxidation to sulfate 1.0 5.0 10.0 0.1149745986461117 0.0 0.0 0.0 0.0 |
| Sulfur amino acid metabolism 2.0 22.0 4.069672131147541 0.097689242801984 0.0 0.0 0.0 0.0 |
| Sumo is conjugated to e1 uba2 sae1 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is proteolytically processed 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is transferred from e1 to e2 ube2i ubc9 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation 2.0 155.0 0.5248580306439515 0.8921604480272981 0.0 0.0 0.0 0.0 |
| Sumoylation of chromatin organization proteins 1.0 58.0 0.7084138918725384 0.7584198129875613 0.0 0.0 0.0 0.0 |
| Sumoylation of dna damage response and repair proteins 2.0 76.0 1.0939299955693398 0.5509866648628524 0.0 0.0 0.0 0.0 |
| Sumoylation of dna methylation proteins 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of dna replication proteins 1.0 46.0 0.8984126984126984 0.6756630435254583 0.0 0.0 0.0 0.0 |
| Sumoylation of immune response proteins 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of intracellular receptors 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of rna binding proteins 1.0 47.0 0.878793256433008 0.6835238209809511 0.0 0.0 0.0 0.0 |
| Sumoylation of sumoylation proteins 1.0 35.0 1.190396158463385 0.5752475783862557 0.0 0.0 0.0 0.0 |
| Sumoylation of transcription cofactors 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of transcription factors 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of ubiquitinylation proteins 1.0 39.0 1.0646616541353384 0.6149168035506691 0.0 0.0 0.0 0.0 |
| Suppression of apoptosis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Suppression of phagosomal maturation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Surfactant metabolism 1.0 8.0 5.797667638483965 0.1775366954381628 0.0 0.0 0.0 0.0 |
| Switching of origins to a post replicative state 2.0 85.0 0.9744222792810586 0.6121025308473456 0.0 0.0 0.0 0.0 |
| Synaptic adhesion like molecules 1.0 11.0 4.057142857142857 0.2356930071839008 0.0 0.0 0.0 0.0 |
| Syndecan interactions 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 12 eicosatetraenoic acid derivatives 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 15 eicosatetraenoic acid derivatives 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 16 20 hydroxyeicosatetraenoic acids hete 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 5 eicosatetraenoic acids 1.0 3.0 10.0 0.0706557803630322 0.0 0.0 0.0 0.0 |
| Synthesis of active ubiquitin roles of e1 and e2 enzymes 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 24 hydroxycholesterol 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 27 hydroxycholesterol 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 7alpha hydroxycholesterol 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of diphthamide eef2 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of dna 2.0 117.0 0.7009978617248752 0.7782590433280002 0.0 0.0 0.0 0.0 |
| Synthesis of dolichyl phosphate 1.0 5.0 10.0 0.1149745986461117 0.0 0.0 0.0 0.0 |
| Synthesis of epoxy eet and dihydroxyeicosatrienoic acids dhet 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of gdp mannose 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of glycosylphosphatidylinositol gpi 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ip2 ip and ins in the cytosol 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ip3 and ip4 in the cytosol 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ketone bodies 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of leukotrienes lt and eoxins ex 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of lipoxins lx 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pa 3.0 25.0 5.5712682379349046 0.0215683584236732 0.0 0.0 0.0 0.0 |
| Synthesis of pc 2.0 22.0 4.069672131147541 0.097689242801984 0.0 0.0 0.0 0.0 |
| Synthesis of pe 2.0 12.0 8.147540983606557 0.032628233248221 0.0 0.0 0.0 0.0 |
| Synthesis of pg 2.0 8.0 10.0 0.0147480216610697 0.0 0.0 0.0 0.0 |
| Synthesis of pi 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the early endosome membrane 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the er membrane 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the golgi membrane 1.0 15.0 2.896793002915452 0.3069124011154697 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the late endosome membrane 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the plasma membrane 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of prostaglandins pg and thromboxanes tx 1.0 8.0 5.797667638483965 0.1775366954381628 0.0 0.0 0.0 0.0 |
| Synthesis of pyrophosphates in the cytosol 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of substrates in n glycan biosythesis 3.0 44.0 2.983739837398374 0.0893115916137597 0.0 0.0 0.0 0.0 |
| Synthesis of udp n acetyl glucosamine 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of very long chain fatty acyl coas 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of wybutosine at g37 of trna phe 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis secretion and deacylation of ghrelin 1.0 5.0 10.0 0.1149745986461117 0.0 0.0 0.0 0.0 |
| Synthesis secretion and inactivation of glucagon like peptide 1 glp 1 1.0 12.0 3.687940630797774 0.2541534411772372 0.0 0.0 0.0 0.0 |
| Synthesis secretion and inactivation of glucose dependent insulinotropic polypeptide gip 1.0 9.0 5.072448979591837 0.1973959389561772 0.0 0.0 0.0 0.0 |
| Tak1 activates nfkb by phosphorylation and activation of ikks complex 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tandem pore domain potassium channels 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tbc rabgaps 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tcf dependent signaling in response to wnt 1.0 142.0 0.2839484730062238 0.9695771599174436 0.0 0.0 0.0 0.0 |
| Tcr signaling 1.0 85.0 0.4793974732750243 0.8756499730029537 0.0 0.0 0.0 0.0 |
| Telomere c strand lagging strand synthesis 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Telomere c strand synthesis initiation 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Telomere extension by telomerase 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Telomere maintenance 0.0 74.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Terminal pathway of complement 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Termination of o glycan biosynthesis 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Termination of translesion dna synthesis 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tetrahydrobiopterin bh4 synthesis recycling salvage and regulation 1.0 7.0 6.764625850340136 0.1571881112173651 0.0 0.0 0.0 0.0 |
| Tfap2 ap 2 family regulates transcription of cell cycle factors 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2 ap 2 family regulates transcription of growth factors and their receptors 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2a acts as a transcriptional repressor during retinoic acid induced cell differentiation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tgf beta receptor signaling activates smads 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tgf beta receptor signaling in emt epithelial to mesenchymal transition 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The activation of arylsulfatases 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The canonical retinoid cycle in rods twilight vision 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The citric acid tca cycle and respiratory electron transport 15.0 160.0 4.390953873712494 7.09125008356695e-06 0.0 0.0 0.0 0.0 |
| The fatty acid cycling model 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The nlrp3 inflammasome 1.0 10.0 4.508390022675737 0.2167775624926856 0.0 0.0 0.0 0.0 |
| The phototransduction cascade 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The retinoid cycle in cones daylight vision 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The role of gtse1 in g2 m progression after g2 checkpoint 1.0 67.0 0.6112554112554113 0.8063536449390534 0.0 0.0 0.0 0.0 |
| The role of nef in hiv 1 replication and disease pathogenesis 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Thrombin signalling through proteinase activated receptors pars 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Thromboxane signalling through tp receptor 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 dependent activation of irf3 irf7 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 rip1 mediated ikk complex recruitment 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 traf6 dependent induction of tak1 complex 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tie2 signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tight junction interactions 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tlr3 mediated ticam1 dependent programmed cell death 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnf receptor superfamily tnfsf members mediating non canonical nf kb pathway 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnf signaling 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr1 induced nfkappab signaling pathway 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr1 induced proapoptotic signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr1 mediated ceramide production 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr2 non canonical nf kb pathway 1.0 58.0 0.7084138918725384 0.7584198129875613 0.0 0.0 0.0 0.0 |
| Tnfs bind their physiological receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toll like receptor 9 tlr9 cascade 0.0 75.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toll like receptor cascades 0.0 103.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toll like receptor tlr1 tlr2 cascade 0.0 70.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toxicity of botulinum toxin type d botd 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates metabolic genes 2.0 84.0 0.98640543782487 0.605635571643147 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of caspase activators and caspases 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of cell cycle genes 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of cell death genes 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of death receptors and ligands 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of dna repair genes 1.0 61.0 0.6727891156462585 0.7755841231055027 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in cytochrome c release 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in g1 cell cycle arrest 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in g2 cell cycle arrest 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of several additional cell death genes whose specific roles in p53 dependent apoptosis remain uncertain 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf3 dependent irf activation pathway 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated induction of tak1 complex within tlr4 complex 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated irf7 activation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated irf7 activation in tlr7 8 or 9 signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated nf kb activation 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking and processing of endosomal tlr 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of ampa receptors 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of glur2 containing ampa receptors 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of myristoylated proteins to the cilium 1.0 4.0 10.0 0.0930847686914372 0.0 0.0 0.0 0.0 |
| Trail signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trans golgi network vesicle budding 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription coupled nucleotide excision repair tc ner 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription of e2f targets under negative control by dream complex 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription of e2f targets under negative control by p107 rbl1 and p130 rbl2 in complex with hdac1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription of the hiv genome 1.0 67.0 0.6112554112554113 0.8063536449390534 0.0 0.0 0.0 0.0 |
| Transcriptional activation of mitochondrial biogenesis 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional activity of smad2 smad3 smad4 heterotrimer 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by e2f6 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by mecp2 1.0 45.0 0.9189239332096476 0.6676078298658026 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx1 2.0 149.0 0.5466153674584588 0.8787741769468748 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx2 1.0 100.0 0.4061430632859204 0.9140832188695428 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx3 1.0 86.0 0.4737094837935174 0.8786754014285567 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by small rnas 1.0 57.0 0.7211370262390671 0.7524126639072135 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by the ap 2 tfap2 family of transcription factors 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by tp53 3.0 333.0 0.3598952487841377 0.9883396969977136 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by ventx 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of granulopoiesis 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of pluripotent stem cells 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of testis differentiation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of white adipocyte differentiation 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transferrin endocytosis and recycling 2.0 18.0 5.089139344262295 0.0688460117016781 0.0 0.0 0.0 0.0 |
| Translation 6.0 289.0 0.8539752650176679 0.7025390861141132 0.0 0.0 0.0 0.0 |
| Translation of replicase and assembly of the replication transcription complex 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation of sars cov 1 structural proteins 1.0 22.0 1.9298347910592808 0.4160065505344545 0.0 0.0 0.0 0.0 |
| Translation of sars cov 2 structural proteins 1.0 41.0 1.0112244897959184 0.6333450487016228 0.0 0.0 0.0 0.0 |
| Translesion synthesis by polh 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by polk 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by y family dna polymerases bypasses lesions on dna template 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translocation of slc2a4 glut4 to the plasma membrane 1.0 66.0 0.6207221350078493 0.8015340371466311 0.0 0.0 0.0 0.0 |
| Transmission across chemical synapses 1.0 139.0 0.2902099970422951 0.9672305971958756 0.0 0.0 0.0 0.0 |
| Transport and synthesis of paps 1.0 4.0 10.0 0.0930847686914372 0.0 0.0 0.0 0.0 |
| Transport of bile salts and organic acids metal ions and amine compounds 1.0 32.0 1.3059907834101383 0.5428479192551358 0.0 0.0 0.0 0.0 |
| Transport of connexons to the plasma membrane 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of fatty acids 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of inorganic cations anions and amino acids oligopeptides 3.0 44.0 2.983739837398374 0.0893115916137597 0.0 0.0 0.0 0.0 |
| Transport of mature mrnas derived from intronless transcripts 1.0 43.0 0.9628765792031098 0.6508948194595567 0.0 0.0 0.0 0.0 |
| Transport of mature transcript to cytoplasm 1.0 81.0 0.5035714285714286 0.8627781534140635 0.0 0.0 0.0 0.0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of nucleotide sugars 1.0 4.0 10.0 0.0930847686914372 0.0 0.0 0.0 0.0 |
| Transport of organic anions 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of small molecules 24.0 377.0 2.939131766327234 1.339794112872063e-05 0.0 0.0 0.0 0.0 |
| Transport of the slbp dependant mature mrna 1.0 36.0 1.156268221574344 0.5855309260576435 0.0 0.0 0.0 0.0 |
| Transport of vitamins nucleosides and related molecules 1.0 21.0 2.026530612244898 0.4015375820029667 0.0 0.0 0.0 0.0 |
| Transport to the golgi and subsequent modification 7.0 148.0 2.0375382058814804 0.0670546193669445 0.0 0.0 0.0 0.0 |
| Trif mediated programmed cell death 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride biosynthesis 1.0 7.0 6.764625850340136 0.1571881112173651 0.0 0.0 0.0 0.0 |
| Triglyceride catabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride metabolism 1.0 20.0 2.133404940923738 0.3867116248199588 0.0 0.0 0.0 0.0 |
| Tristetraprolin ttp zfp36 binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna aminoacylation 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna modification in the mitochondrion 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna modification in the nucleus and cytosol 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna processing 1.0 109.0 0.3719576719576719 0.9311947942836822 0.0 0.0 0.0 0.0 |
| Trna processing in the mitochondrion 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna processing in the nucleus 1.0 60.0 0.6842615012106538 0.7700020901590743 0.0 0.0 0.0 0.0 |
| Trp channels 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tryptophan catabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Type i hemidesmosome assembly 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tyrosine catabolism 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tysnd1 cleaves peroxisomal proteins 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ub specific processing proteases 4.0 151.0 1.1022656996682971 0.496570496477997 0.0 0.0 0.0 0.0 |
| Ubiquinol biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uch proteinases 1.0 79.0 0.5165881737310308 0.8558530274917338 0.0 0.0 0.0 0.0 |
| Unblocking of nmda receptors glutamate binding and activation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Unfolded protein response upr 6.0 75.0 3.580072463768116 0.0093312143417945 0.0 0.0 0.0 0.0 |
| Unwinding of dna 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and actions of bacterial toxins 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and function of anthrax toxins 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and function of diphtheria toxin 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Urea cycle 1.0 6.0 8.118367346938776 0.1363381791325428 0.0 0.0 0.0 0.0 |
| Vasopressin regulates renal water homeostasis via aquaporins 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegf ligand receptor interactions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegfr2 mediated cell proliferation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegfr2 mediated vascular permeability 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vesicle mediated transport 15.0 546.0 1.1518331009856433 0.3391224277718983 0.0 0.0 0.0 0.0 |
| Viral messenger rna synthesis 1.0 44.0 0.9403891789273848 0.6593533907576883 0.0 0.0 0.0 0.0 |
| Visual phototransduction 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b1 thiamin metabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b2 riboflavin metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b5 pantothenate metabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin c ascorbate metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin d calciferol metabolism 2.0 8.0 10.0 0.0147480216610697 0.0 0.0 0.0 0.0 |
| Vldl assembly 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldl clearance 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldlr internalisation and degradation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Voltage gated potassium channels 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vxpx cargo targeting to cilium 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wax and plasmalogen biosynthesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt ligand biogenesis and trafficking 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt mediated activation of dvl 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt5a dependent internalization of fzd2 fzd5 and ror2 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt5a dependent internalization of fzd4 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Xenobiotics 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Yap1 and wwtr1 taz stimulated gene expression 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zbp1 dai mediated induction of type i ifns 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc efflux and compartmentalization by the slc30 family 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc influx into cells by the slc39 gene family 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc transporters 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
|
|
